Advanced in Chronic B-Cell Leukemia (CBCL)

Dr. Ian D. Schnadig

Internal Medicine | Oncology
Providence
12123 Southwest 69th Avenue, 
Tigard, OR 
Accepting New Patients
Offers Telehealth
Advanced in Chronic B-Cell Leukemia (CBCL)
Providence
12123 Southwest 69th Avenue, 
Tigard, OR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ian Schnadig is an Internal Medicine specialist and an Oncologist in Tigard, Oregon. Dr. Schnadig is rated as an Advanced provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Prostate Cancer, Breast Cancer, Familial Colorectal Cancer, and Familial Prostate Cancer. Dr. Schnadig is currently accepting new patients.

His clinical research consists of co-authoring 19 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Oncology
Licenses
Internal Medicine in OR
Hospital Affiliations
Legacy Meridian Park Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Prominence Health
  • EPO
  • PPO
Regence
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

12123 Southwest 69th Avenue, Tigard, OR 97223
Call: 971-708-7600

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2, Randomized, Open-Label Study of Trilaciclib Administered With First-Line Platinum-Based Chemotherapy and Avelumab Maintenance Therapy in Patients With Untreated, Locally Advanced or Metastatic Urothelial Carcinoma (PRESERVE 3)
A Phase 2, Randomized, Open-Label Study of Trilaciclib Administered With First-Line Platinum-Based Chemotherapy and Avelumab Maintenance Therapy in Patients With Untreated, Locally Advanced or Metastatic Urothelial Carcinoma (PRESERVE 3)
Enrollment Status: Terminated
Publish Date: September 08, 2025
Intervention Type: Drug
Study Drugs: Trilaciclib, Gemcitabine, Cisplatin, Carboplatin, Avelumab
Study Phase: Phase 2
A Double-Blinded, Placebo-Controlled, Randomized Phase II Study of Enzalutamide With or Without the PI3 Kinase/mTOR Inhibitor LY3023414 in Men With Metastatic Castration Resistant Prostate Cancer
A Double-Blinded, Placebo-Controlled, Randomized Phase II Study of Enzalutamide With or Without the PI3 Kinase/mTOR Inhibitor LY3023414 in Men With Metastatic Castration Resistant Prostate Cancer
Enrollment Status: Completed
Publish Date: May 11, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double Blind, Multicenter, Parallel-group, Phase III Study to Evaluate Efficacy and Safety of DCVAC/PCa Versus Placebo in Men With Metastatic Castration Resistant Prostate Cancer Eligible for 1st Line Chemotherapy
A Randomized, Double Blind, Multicenter, Parallel-group, Phase III Study to Evaluate Efficacy and Safety of DCVAC/PCa Versus Placebo in Men With Metastatic Castration Resistant Prostate Cancer Eligible for 1st Line Chemotherapy
Enrollment Status: Completed
Publish Date: April 06, 2021
Intervention Type: Biological
Study Phase: Phase 3
View 2 Less Clinical Trials

19 Total Publications

Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer.
Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 29, 2021
View All 19 Publications
Similar Doctors
Elite in Chronic B-Cell Leukemia (CBCL)
Dr. Stephen E. Spurgeon
Hematology | Oncology
Elite in Chronic B-Cell Leukemia (CBCL)
Dr. Stephen E. Spurgeon
Hematology | Oncology

University Professional Services

15700 Sw Greystone Ct, 
Beaverton, OR 
 (5.9 miles away)
503-494-3442
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Stephen Spurgeon is a Hematologist and an Oncologist in Beaverton, Oregon. Dr. Spurgeon is rated as an Elite provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Mantle Cell Lymphoma (MCL), Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Spurgeon is currently accepting new patients.

Advanced in Chronic B-Cell Leukemia (CBCL)
Dr. Xinyu S. Fu
Oncology | Hematology | Hematology Oncology
Advanced in Chronic B-Cell Leukemia (CBCL)
Dr. Xinyu S. Fu
Oncology | Hematology | Hematology Oncology

University Professional Services

15700 Sw Greystone Ct, 
Beaverton, OR 
 (5.9 miles away)
503-494-3442
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients
Offers Telehealth

Xinyu Fu is an Oncologist and a Hematologist in Beaverton, Oregon. Dr. Fu is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Richter Syndrome, Chronic Lymphocytic Leukemia (CLL), Bone Tumor, and Undifferentiated Pleomorphic Sarcoma. Dr. Fu is currently accepting new patients.

Distinguished in Chronic B-Cell Leukemia (CBCL)
Dr. Bret A. Cook
Hematology Oncology | Oncology | Hematology
Distinguished in Chronic B-Cell Leukemia (CBCL)
Dr. Bret A. Cook
Hematology Oncology | Oncology | Hematology

Oregon Oncology Specialists Llp

875 Oak St Se, Suite 4030, 
Salem, OR 
 (37.2 miles away)
503-561-6444
Languages Spoken:
English
See accepted insurances

Bret Cook is a Hematologist Oncology specialist and an Oncologist in Salem, Oregon. Dr. Cook is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration.

VIEW MORE CHRONIC B-CELL LEUKEMIA (CBCL) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Schnadig's expertise for a condition
ConditionClose
    • Distinguished
    • Breast Cancer
      Dr. Schnadig is
      Distinguished
      . Learn about Breast Cancer.
      See more Breast Cancer experts
    • Colorectal Cancer
      Dr. Schnadig is
      Distinguished
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    • Familial Colorectal Cancer
      Dr. Schnadig is
      Distinguished
      . Learn about Familial Colorectal Cancer.
      See more Familial Colorectal Cancer experts
    • Familial Prostate Cancer
      Dr. Schnadig is
      Distinguished
      . Learn about Familial Prostate Cancer.
      See more Familial Prostate Cancer experts
    • Multiple Myeloma
      Dr. Schnadig is
      Distinguished
      . Learn about Multiple Myeloma.
      See more Multiple Myeloma experts
    • Paget Disease of the Breast
      Dr. Schnadig is
      Distinguished
      . Learn about Paget Disease of the Breast.
      See more Paget Disease of the Breast experts
    View All 8 Distinguished Conditions
    • Advanced
    • Agranulocytosis
      Dr. Schnadig is
      Advanced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • Anal Cancer
      Dr. Schnadig is
      Advanced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Bladder Cancer
      Dr. Schnadig is
      Advanced
      . Learn about Bladder Cancer.
      See more Bladder Cancer experts
    • Choriocarcinoma
      Dr. Schnadig is
      Advanced
      . Learn about Choriocarcinoma.
      See more Choriocarcinoma experts
    • Chronic B-Cell Leukemia (CBCL)
      Dr. Schnadig is
      Advanced
      . Learn about Chronic B-Cell Leukemia (CBCL).
      See more Chronic B-Cell Leukemia (CBCL) experts
    • Chronic Familial Neutropenia
      Dr. Schnadig is
      Advanced
      . Learn about Chronic Familial Neutropenia.
      See more Chronic Familial Neutropenia experts
    View All 26 Advanced Conditions
    • Experienced
    • Adrenal Cancer
      Dr. Schnadig is
      Experienced
      . Learn about Adrenal Cancer.
      See more Adrenal Cancer experts
    • Adrenocortical Carcinoma
      Dr. Schnadig is
      Experienced
      . Learn about Adrenocortical Carcinoma.
      See more Adrenocortical Carcinoma experts
    • Adult Soft Tissue Sarcoma
      Dr. Schnadig is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Schnadig is
      Experienced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Ampullary Cancer
      Dr. Schnadig is
      Experienced
      . Learn about Ampullary Cancer.
      See more Ampullary Cancer experts
    • Angiosarcoma
      Dr. Schnadig is
      Experienced
      . Learn about Angiosarcoma.
      See more Angiosarcoma experts
    View All 82 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.